Selected article for: "angiotensin receptor blocker and receptor blocker"

Author: Samuel J. S. Rubin; Samuel Robert Falkson; Nicholas Degner; Catherine Blish
Title: Clinical characteristics associated with COVID-19 severity in California
  • Document date: 2020_3_30
  • ID: as6tbfrh_8
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.27.20043661 doi: medRxiv preprint prevalence (Fisher's exact test, p = 0.671) (2, 3) . Angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) use in 9 patients (16.7%) was also not significantly different from the US prevalence (Fisher's exact test, p = 1.000) (4)......
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03.27.20043661 doi: medRxiv preprint prevalence (Fisher's exact test, p = 0.671) (2, 3) . Angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) use in 9 patients (16.7%) was also not significantly different from the US prevalence (Fisher's exact test, p = 1.000) (4).

    Search related documents:
    Co phrase search for related documents